Brief: Helix Biopharma Reports Q2 Loss Per Share of C$0.03
20/03/2018 24:36
March 19 (Reuters) - Helix Biopharma Corp HBP.TO :
* . ANNOUNCES FISCAL SECOND QUARTER 2018 RESULTS
* Q2 LOSS PER SHARE C$0.03
Source text for Eikon: ID:nGNX1TKjjq
Further company coverage: HBP.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Helix Biopharma
See all newsBrief: Helix Biopharma Reports Q3 Loss Per Share C$0.02
Brief: Helix Biopharma Intends To File Interim Consolidated Financial Statements By July 30
Brief: Helix Biopharma To Divest Remaining Ownership Of Polish Subsidiary
Brief: Helix Biopharma Says Expects To File Interim Disclosure Documents By July 30, 2020
Brief: Helix Biopharma Says L-Dos47 Phase I Lung Cancer Trial Data To Be Released At Asco 2020